J. Berger

发表

Biochemical properties of D1 and D2 dopamine receptors.

M. Caron, S. Senogles, N. Amlaiky, 1988, Advances in experimental medicine and biology.

SCH 57790: a novel M2 receptor selective antagonist.

C. Strader, J. Lachowicz, J. Clader, 1999, Life sciences.

Chapter 3. Anti-Anxiety Agents, Anticonvulsants, and Sedative-Hypnotics

L. Iorio, J. Berger, 1980 .

An unusual stereospecific reduction of some basic side-chain substituted indoles.

L. Guggenberger, J. Berger, S. Teller, 1975 .

Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesic.

R. Chapman, A. Barnett, R. Chipkin, 1988, The Journal of pharmacology and experimental therapeutics.

Inhibitors of acyl CoA:cholesterol acyltransferase.

R. Burrier, J. Clader, J. Berger, 1996, Journal of medicinal chemistry.

Heterocyclic synthesis from o-aminonitriles. XXIX. A new synthesis of 5-substituted pyrimidines

E. Taylor, J. Berger, 1967 .

A New Synthesis of 5‐Substituted Pyrimidines

E. Taylor, J. Berger, 1966 .

A Rapid Convenient Reduction of Indoles to Indolines and of Tetrahydrocarbazoles to Hexahydrocarbazoles by Trimethylamine/Borane

J. Berger, 1974 .

Application of an almost traceless linker in the synthesis of 2-alkylthiobenzimidazole combinatorial libraries

J. Berger, M. Phillips, Rachel M. Slade, 2004, Molecular Diversity.

Dopamine receptor binding properties of some 2,3,4,5-tetrahydro-1H-3-benzazepine-7-ols with non-aromatic substituents in the 5-position

H. Guzik, R. Mcquade, G. Zhou, 1992 .

DEHYDROHALOGENATION OF NEOALKYL HALIDES BY STRONG BASE: EVIDENCE OF CARBENE INTERMEDIATES1

L. Friedman, J. Berger, 1961 .

Carbenoid species from methyl and methylene halides

L. Friedman, J. Berger, R. Honour, 1970 .

Substituted (1,2-diarylethyl)amide acyl-CoA:cholesterol acyltransferase inhibitors: effect of polar groups on in vitro and in vivo activity.

R. Burrier, J. Clader, H. Davis, 1995, Journal of medicinal chemistry.

Reaction of pyrrole ketones with formaldehyde. Formation of N‐pyrrolemethanols

J. Berger, K. Schoen, 1972 .

Synthesis of some conformationally restricted analogues of fentanyl.

F. Davidson, G. Langford, J. Berger, 1977, Journal of medicinal chemistry.

Stereochemically complementary reductions of indoles

A. McPhail, K. Onan, J. Berger, 1983 .

8 - Agents Affecting the Central Nervous System

J. Fukunaga, J. Berger, 1983 .

Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol.

J. Clader, A. McPhail, D. Hou, 1989, Journal of medicinal chemistry.

CARBENE BY THE DEHYDROHALOGENATION OF METHYL CHLORIDE

L. Friedman, J. Berger, 1960 .

Cycloalkapyrrolones via decarboxylative ring closure of pyrrole-3-alkanoic acids and derivatives.

I. J. Pachter, J. Berger, S. Teller, 1970, The Journal of organic chemistry.

Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.

R. Mcquade, A. Barnett, V. Coffin, 1988, The Journal of pharmacology and experimental therapeutics.

Affinity chromatography of the D1 dopamine receptor from rat corpus striatum.

M. Caron, J. Gingrich, R. Mcquade, 1988, Biochemistry.

Solid-Phase Synthesis of 2-Aminotetrahydropyrimidines

J. Berger, V. Jammalamadaka, 2000 .

Isolation And Biochemical Characterization Of The D1 And D2 Dopamine Receptors

M. Caron, J. Gingrich, S. Senogles, 1988 .

Inherently Dissymmetric Chromophores. Optical Activity Associated with a Homoconjugated Diene

K. Mislow, L. Forster, A. Moscowitz, 1962 .

The Synthesis of Tetravinylmethane

E. L. Stogryn, A. Zimmerman, J. Berger, 1964 .

Identification of the binding subunit of the D1-dopamine receptor by photoaffinity crosslinking.

M. Caron, R. Mcquade, N. Amlaiky, 1986, Molecular pharmacology.